Literature DB >> 10501756

Inhaled nitric oxide improves hemodynamics during a venous air infusion (VAI) in dogs.

J E Tanus-Santos1, H Moreno, R A Moreno, M L Martins, R Pereira, G de Nucci.   

Abstract

OBJECTIVE: To evaluate the hemodynamic effects of inhaled nitric oxide (NO) during a venous air infusion (VAI) in dogs. We also addressed the question of whether NO therapy changes thromboxane (Tx) A(2) release and nitrate/nitrite production during a VAI.
DESIGN: Prospective trial.
SETTING: University laboratory.
INTERVENTIONS: Anesthetized mongrel dogs received a VAI (0.2 ml x kg(-1)x min(-1)) after the measurement of baseline hemodynamics. Control dogs (n = 8) received no further treatment. After 30 min of VAI, NO 3 ppm inhalation was initiated (n = 7) for 30 min, followed by 30 min without NO inhalation, and then a final 30 min of NO 40 ppm treatment. Hemodynamic variables were registered and arterial and mixed venous blood samples were drawn for gas analysis and for the determinations of serum TxB(2) (by enzyme-linked immunosorbent assay) and nitrate/nitrite (by high-performance liquid chromatography) levels.
RESULTS: The cardiac index increased 24 % and the pulmonary vascular resistance index decreased 30 % during both periods of NO inhalation. Arterial oxygen tension and arterial oxygen saturation were slightly lower after NO therapy. Nitrate/nitrite concentrations were unaltered in the control group and there were no differences between the arterial and mixed venous serum nitrate/nitrite levels. Nitrite concentrations remained below 1 microM in both groups of animals, but the nitrate concentration increased after inhalation of 40 ppm NO. Serum TxB(2) increased after 60 min of VAI in the control group, but there was no increase in NO-treated animals (all p < 0.05)
CONCLUSIONS: Nitrate/nitrite concentrations were unaltered after VAI in dogs. NO therapy attenuated TxA(2) release and improved hemodynamics, but not blood oxygenation, in dogs with a VAI. There were no differences between the responses to 3 ppm and 40 ppm NO.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501756     DOI: 10.1007/s001340050993

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  3 in total

1.  The effect of a combination of inhaled nitric oxide and an endothelinA-receptor antagonist on hemodynamic dysfunction in experimental acute pulmonary thromboembolism.

Authors:  Ji-Hyun Lee; Sehyun Kim; Byung-Kyu Park; Woo-Sung Kim; Dong-Soon Kim; Won-Dong Kim; Sang-Do Lee
Journal:  Lung       Date:  2005 Mar-Apr       Impact factor: 2.584

2.  Increased expired NO and roles of CO2 and endogenous NO after venous gas embolism in rabbits.

Authors:  Per Agvald; L Christofer Adding; Kristofer F Nilsson; Lars E Gustafsson; Dag Linnarsson
Journal:  Eur J Appl Physiol       Date:  2006-04-21       Impact factor: 3.078

3.  Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes.

Authors:  Carlos A Dias; Evandro M Neto-Neves; Marcelo F Montenegro; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-10-02       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.